By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Akonni Biosystems today announced the National Institutes of Health has awarded it $300,000 to develop nucleic acid extraction and microarray-based testing systems for the identification of human disease in cerebrospinal fluid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.